NMDA receptors mediate calcium accumulation in myelin during chemical ischaemia

Nature

Volumn 439, Issue 7079, 2006, Pages 988-992

  Micu, I ^a   Jiang, Q ^a   Coderre, E ^a   Ridsdale, A ^a   Zhang, L ^a   Woulfe, J ^a   Yin, X ^b   Trapp, B D ^b   McRory, J E ^c   Rehak, R ^c   Zamponi, G W ^c   Wang, W ^a   Stys, P K ^a  

^a OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^b LERNER RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CELLS; DISEASES; PHOTONS;

CHEMICAL ISCHAEMIA; IMMUNOPRECIPITATION; NEUROLOGICAL MORBIDITY;

CALCIUM;

6 NITRO 7 SULFAMOYLBENZO[F]QUINOXALINE 2,3 DIONE; 7 CHLOROKYNURENIC ACID; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; CALCIUM; DIZOCILPINE; GLUTAMATE RECEPTOR; IFENPRODIL; KAINIC ACID RECEPTOR ANTAGONIST; MYELIN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 1; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2A; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2B; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

NEUROLOGY;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN INJURY; BRAIN ISCHEMIA; CELL COMPARTMENTALIZATION; CELL DAMAGE; CELL ULTRASTRUCTURE; CENTRAL NERVOUS SYSTEM; CHEMICAL REACTION; CONTROLLED STUDY; DEMYELINATING DISEASE; ENCEPHALOMYOPATHY; FLUORESCENCE MICROSCOPY; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; ISCHEMIA; MULTIPLE SCLEROSIS; MYELIN SHEATH; NERVOUS SYSTEM INJURY; NONHUMAN; OLIGODENDROGLIA; OPTIC NERVE; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; STIMULUS RESPONSE; TISSUE INJURY;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS;

EID: 33644520285     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature04474     Document Type: Article

References (30)

1. Waxman, S. G., Kocsis, J. D. & Stys, P. K. The Axon: Structure, Function and Pathophysiology (Oxford Univ. Press, Oxford, 1995).
2. Dingledine, R., Borges, K., Bowie, D. & Traynelis, S. F. The glutamate receptor ion channels. Pharmacol. Rev. 51, 7-61 (1999).
3. Waxman, E. A. & Lynch, D. R. N-methyl-D-aspartate receptor subtypes: multiple roles in excitotoxicity and neurological disease. Neuroscientist 11, 37-49 (2005).
4. Parsons, C. G., Danysh, W. & Quack, G. Glutamate in CNS disorders as a target for drug development: an update. Drug News Perspect. 11, 523-569 (1998).
5. Auberson, Y. P. et al. 5-phosphonomethylquinoxalinediones as competitive NMDA receptor antagonists with a preference for the human 1A/2A, rather than 1A/2B receptor composition. Bioorg. Med. Chem. Lett. 12, 1099-1102 (2002).
6. Waxman, S. G., Black, J. A., Stys, P. K. & Ransom, B. R. Ultrastructural concomitants of anoxic injury and early post-anoxic recovery in rat optic nerve. Brain Res. 574, 105-119 (1992).
7. Lin, S. C. et al. Climbing fiber innervation of NG2-expressing glia in the mammalian cerebellum. Neuron 46, 773-785 (2005).
8. +-dependent glutamate transport. J. Neurosci. 19, RC16 (1999).
9. Chiu, S. Y. & Kriegler, S. Neurotransmitter-mediated signalling between axons and glial cells. Glia 11, 191-200 (1994).
10. Matute, C., Alberdi, E., Ibarretxe, G. & Sanchez-Gomez, M. V. Excitotoxicity in glial cells. Eur. J. Pharmacol. 447, 239-246 (2002).
11. Ziak, D., Chvatal, A. & Sykova, E. Glutamate-, kainate- and NMDA-evoked membrane currents in identified glial cells in rat spinal cord slice. Physiol. Res. 47, 365-375 (1998).
12. Das, S. et al. Increased NMDA current and spine density in mice lacking the NMDA receptor subunit NR3A. Nature 393, 377-381 (1998).
13. McDonald, J. W., Althomsons, S. P., Hyrc, K. L., Choi, D. W. & Goldberg, M. P. Oligodendrocytes from forebrain are highly vulnerable to AMPA/kainate receptor-mediated excitotoxicity. Nature Med. 4, 291-297 (1998).
14. Rosenberg, P. A. et al. Mature myelin basic protein-expressing oligodendrocytes are insensitive to kainate toxicity. J. Neurosci. Res. 71, 237-245 (2003).
15. Lazzarini, R. A. et al. Myelin Biology and Disorders (Elsevier, Amsterdam, 2004).
16. Michailov, G. V. et al. Axonal neuregulin-1 regulates myelin sheath thickness. Science 304, 700-703 (2004).
17. Quarles, R. H., Macklin, W. B. & Morell, P. in Basic Neurochemistry (eds Siegel, G. J., Albers, R. W., Brady, S. T. & Price, D. L.) 51-72 (Elsevier, San Diego, in the press).
18. +-dependent, p-nitrophenyl phosphatase in myelin. Brain Res. 343, 154-158 (1985).
19. Kamasawa, N. et al. Connexin-47 and connexin-32 in gap junctions of oligodendrocyte somata, myelin sheaths, paranodal loops and Schmidt-Lanterman incisures: implications for ionic homeostasis and potassium siphoning. Neuroscience 136, 65-85 (2005).
20. Brand-Schieber, E. & Werner, P. AMPA/kainate receptors in mouse spinal cord: cell-specific display of receptor subunits by oligodendrocytes and astrocytes and at the nodes of Ranvier. Glia 42, 12-24 (2003).
21. Li, S. & Stys, P. K. Mechanisms of ionotropic glutamate receptor-mediated excitotoxicity in isolated spinal cord white matter. J. Neurosci. 20, 1190-1198 (2000).
22. Hinman, J. D., Duce, J. A., Siman, R. A., Hollander, W. & Abraham, C. R. Activation of calpain-1 in myelin and microglia in the white matter of the aged rhesus monkey. J. Neurochem. 89, 430-441 (2004).
23. 2+ of NMDA responses in spinal cord neurones. Nature 309, 261-263 (1984).
24. Aragon, C. & Lopez-Corcuera, B. Structure, function and regulation of glycine neurotransporters. Eur. J. Pharmacol. 479, 249-262 (2003).
25. Danbolt, N. C. Glutamate uptake. Prog. Neurobiol. 65, 1-105 (2001).
26. Stys, P. K. White matter injury mechanisms. Curr. Mol. Med. 4, 113-130 (2004).
27. Spike, R. C., Watt, C., Zafra, F. & Todd, A. J. An ultrastructural study of the glycine transporter GLYT2 and its association with glycine in the superficial laminae of the rat spinal dorsal horn. Neuroscience 77, 543-551 (1997).
28. Bear, M. F. & Malenka, R. C. Synaptic plasticity: LTP and LTD. Curr. Opin. Neurobiol. 4, 389-399 (1994).
29. Lipton, S. A. & Rosenberg, P. A. Excitatory amino acids as a final common pathway for neurologic disorders. N. Engl. J. Med. 330, 613-622 (1994).
30. Wallstrom, E. et al. Memantine abrogates neurological deficits, but not CNS inflammation, in Lewis rat experimental autoimmune encephalomyelitis. J. Neurol. Sci. 137, 89-96 (1996).